These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10972374)

  • 41. Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease.
    Tarallo A; Damiano C; Strollo S; Minopoli N; Indrieri A; Polishchuk E; Zappa F; Nusco E; Fecarotta S; Porto C; Coletta M; Iacono R; Moracci M; Polishchuk R; Medina DL; Imbimbo P; Monti DM; De Matteis MA; Parenti G
    EMBO Mol Med; 2021 Nov; 13(11):e14434. PubMed ID: 34606154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elimination of antibodies to recombinant enzyme in Pompe's disease.
    Mendelsohn NJ; Messinger YH; Rosenberg AS; Kishnani PS
    N Engl J Med; 2009 Jan; 360(2):194-5. PubMed ID: 19129538
    [No Abstract]   [Full Text] [Related]  

  • 43. A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease.
    Byrne BJ; Geberhiwot T; Barshop BA; Barohn R; Hughes D; Bratkovic D; Desnuelle C; Laforet P; Mengel E; Roberts M; Haroldsen P; Reilley K; Jayaram K; Yang K; Walsh L;
    Orphanet J Rare Dis; 2017 Aug; 12(1):144. PubMed ID: 28838325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral delivery of Acid Alpha Glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice.
    Su J; Sherman A; Doerfler PA; Byrne BJ; Herzog RW; Daniell H
    Plant Biotechnol J; 2015 Oct; 13(8):1023-32. PubMed ID: 26053072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of immobilized antibodies in investigating acid alpha-glucosidase in urine in relation to Pompe's disease.
    Schram AW; Brouwer-Kelder B; Donker-Koopman WE; Loonen C; Hamers MN; Tager JM
    Biochim Biophys Acta; 1979 Apr; 567(2):370-83. PubMed ID: 36157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fractures in children with Pompe disease: a potential long-term complication.
    Case LE; Hanna R; Frush DP; Krishnamurthy V; DeArmey S; Mackey J; Boney A; Morgan C; Corzo D; Bouchard S; Weber TJ; Chen YT; Kishnani PS
    Pediatr Radiol; 2007 May; 37(5):437-45. PubMed ID: 17342521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Enzyme replacement therapy in a boy with infantile Pompe disease: cardiac follow-up].
    Bonnefoy R; Labarthe F; Paoli F; Chantreuil J; Barthez MA; Froissart R; Poinsot J; Chantepie A
    Arch Pediatr; 2008 Dec; 15(12):1760-4. PubMed ID: 18995995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apical Hypertrophic Cardiomyopathy in an Infant: First Presentation of Pompe's Disease.
    Patra S; Subramaniun A; Mahimaiha J; Sastry UM; Nanjappa MC
    World J Pediatr Congenit Heart Surg; 2014 Jul; 5(3):491-3. PubMed ID: 24958062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease.
    Han SO; Li S; Bird A; Koeberl D
    Hum Gene Ther; 2015 Nov; 26(11):743-50. PubMed ID: 26417913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series.
    Wang LY; Ross AK; Li JS; Dearmey SM; Mackey JF; Worden M; Corzo D; Morgan C; Kishnani PS
    Paediatr Anaesth; 2007 Aug; 17(8):738-48. PubMed ID: 17596219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.
    Raben N; Fukuda T; Gilbert AL; de Jong D; Thurberg BL; Mattaliano RJ; Meikle P; Hopwood JJ; Nagashima K; Nagaraju K; Plotz PH
    Mol Ther; 2005 Jan; 11(1):48-56. PubMed ID: 15585405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Three hypotonic neonates with hypertrophic cardiomyopathy: Pompe's disease].
    Willemsen MA; Jira PE; Gabreëls FJ; van der Ploeg AT; Smeitink JA
    Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1388-92. PubMed ID: 9752027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth.
    Chien YH; Lee NC; Chen CA; Tsai FJ; Tsai WH; Shieh JY; Huang HJ; Hsu WC; Tsai TH; Hwu WL
    J Pediatr; 2015 Apr; 166(4):985-91.e1-2. PubMed ID: 25466677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glycoengineered acid alpha-glucosidase with improved efficacy at correcting the metabolic aberrations and motor function deficits in a mouse model of Pompe disease.
    Zhu Y; Jiang JL; Gumlaw NK; Zhang J; Bercury SD; Ziegler RJ; Lee K; Kudo M; Canfield WM; Edmunds T; Jiang C; Mattaliano RJ; Cheng SH
    Mol Ther; 2009 Jun; 17(6):954-63. PubMed ID: 19277015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease.
    Wang Z; Okamoto P; Keutzer J
    Mol Genet Metab; 2014 Feb; 111(2):92-100. PubMed ID: 24044919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits.
    Jongen SP; Gerwig GJ; Leeflang BR; Koles K; Mannesse ML; van Berkel PH; Pieper FR; Kroos MA; Reuser AJ; Zhou Q; Jin X; Zhang K; Edmunds T; Kamerling JP
    Glycobiology; 2007 Jun; 17(6):600-19. PubMed ID: 17293352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pompe's disease].
    Laforêt P
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S290-1. PubMed ID: 18029059
    [No Abstract]   [Full Text] [Related]  

  • 58. The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-α-glucosidase in Pompe's iPSCs.
    Higuchi T; Kawagoe S; Otsu M; Shimada Y; Kobayashi H; Hirayama R; Eto K; Ida H; Ohashi T; Nakauchi H; Eto Y
    Mol Genet Metab; 2014 May; 112(1):44-8. PubMed ID: 24642446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two cases of Pompe's disease: case report and review of literature.
    Jegadeeswari A; Amuthan V; Janarthanan RA; Murugan S; Balasubramanian S
    Indian Heart J; 2012; 64(2):214-6. PubMed ID: 22572506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac remodeling and contractile function in acid alpha-glucosidase knockout mice.
    Kamphoven JH; Stubenitsky R; Reuser AJ; Van Der Ploeg AT; Verdouw PD; Duncker DJ
    Physiol Genomics; 2001 Apr; 5(4):171-9. PubMed ID: 11328962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.